Middle East & Africa Intradermal Injections Market Forecast to 2028 - COVID-19 Impact and Regional Analysis

Description

List of Tables

The intradermal injections market in Middle East & Africa is expected to grow from US$ 153.37 million in 2021 to US$ 302.27 million by 2028. It is estimated to grow at a CAGR of 10.2% from 2021 to 2028.

Increasing Preference for Intradermal Vaccination Fuels Market Growth

The rising acceptance of intradermal vaccination is believed to act as a major driver for the Middle East & Africa intradermal injection market as it has several advantages over the conventional method of vaccination. Intradermal vaccination helps in reducing the potential dose of antigens, improves the immune response generated by vaccines, and decreases the anxiety associated with the vaccination. By developing intradermal injections, a large population can be vaccinated with comparatively lesser volumes of vaccines. The method would also help authorities in vaccinating the difficult group of population with comorbidities, as the chances of adverse events are lower than that in conventional vaccination. Intradermal vaccines against COVID-19, hepatitis A, hepatitis B, influenza, polio, measles, rabies, tetanus, yellow fever, diphtheria-tetanus-pertussis, etc., show improvement in the overall response rate, and hence, several leading pharmaceutical and biotechnological companies are currently working on the development of intradermal injections of the new as well as already commercialized vaccines. Pfizer got approval for intradermal COVID-19 vaccines-Comirnaty-for vaccinating people of age more than 16. Therefore, the increasing preference for intradermal vaccination boosts the growth of the market in the Middle East & Africa.

Market Overview

The intradermal injections market in the Middle East & Africa is segmented into Saudi Arabia, South Africa, the UAE, and rest of Middle East & Africa. The market in this region is anticipated to grow at a CAGR 19.6% during the forecast period; this growth is attributed to the rising prevalence of various diseases and increasing funding and healthcare-related policies from governments. Saudi Arabia has a national healthcare system, wherein the government offers free medical services through different government-aided medical facilities. The private sector also plays an increasingly important role in the delivery of health care services. Saudi Arabia dominates the pharmaceutical market of the Middle East, which can be ascribed to a vast population base, and the elevating prevalence of several communicable and noncommunicable diseases. The government of Saudi Arabia is promoting and offering several incentives for the domestic manufacturing of medical devices, which, in turn, can drive the overall market growth in this country. Thus, well-developed research centers and focus on increasing research studies for the treatment of various respiratory diseases are expected to fuel the growth of the intradermal injections market in the Middle East & Africa in the coming years. The dependence of Saudi Arabia on export has reduced remarkably in the past few years, primarily due to the increasing involvement of regional players in the market. The factors such as increasing cases of tuberculosis and allergies, rising spending on healthcare, and surging number of immigrants are expected to contribute to the market in this region in the coming years.

Middle East & Africa Intradermal Injections Market Segmentation

The Middle East & Africa intradermal injections market is segmented on the basis of method, application, end user, and country.

Based on method, the market is segmented into normal sized needle, short needle, and without needle. The normal sized needles segment registered the largest market share in 2021. The normal sized needles segment is further sub segmented into intradermal microinjections, microneedle arrays, and tattoo devices. The short needle segment is bifurcated into intradermal liquid jet injectors and ballistic intradermal injectors.

In terms of application, the Middle East & Africa intradermal injections market is segmented into tuberculin skin test, allergy test, local aesthetics, and others. The tuberculin skin test segment held the largest market share in 2021.

The Middle East & Africa intradermal injections market, by end user, is segmented into hospitals, diagnostic laboratories, academics and research institutes, and others. The hospitals segment held the largest market share in 2021.

Based on country, the market is segmented into Saudi Arabia, South Africa, the UAE, and rest of Middle East & Africa. Saudi Arabia dominated the market share in 2021.

BD; West Pharmaceutical Services, Inc; Terumo Corporation; Nanopass; PharmaJet; Idevax; EUNSUNG GLOBAL; Crossject; Cardinal Health Inc; and Hindustan Syringes and Medical Devices Ltd are the leading companies operating in intradermal injections market in the Middle East & Africa region.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa intradermal injections market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa intradermal injections market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the intradermal injections market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Product Code: TIPRE00027990

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 MEA Intradermal Injections Market - By Method
- 1.3.2 MEA Intradermal Injections Market - By Application
- 1.3.3 MEA Intradermal Injections Market - By End User
- 1.3.4 MEA Intradermal Injections Market - By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. MEA Intradermal Injections Market Landscape

4.1 Overview
4.2 MEA PEST ANALYSIS
- 4.2.1 Middle East and Africa PEST Analysis
4.3 EXPERT OPINIONS

5. MEA Intradermal Injections Market - Key Market Dynamics

5.1 Key Market Drivers
- 5.1.1 Increasing Intradermal Vaccination
- 5.1.2 Increasing Incidences of diseases
- 5.1.3 Rising Acceptance of Aesthetic Procedures
5.2 Key Market Restraints
- 5.2.1 Risks, Complications, and Dosing Limitations Associated with Intradermal Injections
5.3 Key Market Opportunities
- 5.3.1 Significant Growth Opportunities in Developed as Well As Developing Countries
5.4 Future Trends
- 5.4.1 Strategic Developments by Manufacturers
5.5 Impact Analysis of Drivers and Restraints

6. Intradermal Injections Market- MEA Analysis

6.1 MEA Intradermal Injections Market, By Country - Forecast and Analysis

7. MEA Intradermal Injections Market Revenue and Forecasts To 2028- By Method

7.1 Overview
7.2 MEA Intradermal Injections Market, By Method, 2021 & 2028 (%)
7.3 Normal-Sized Needles (MANTOUX)
- 7.3.1 Overview
- 7.3.2 Normal-Sized Needles (Mantoux): Intradermal Injection Market Revenue and Forecasts To 2028 (US$ MN)
7.4 Short Needles
- 7.4.1 Overview
- 7.4.2 Short Needles: Intradermal Injection Market Revenue and Forecast to 2028 (US$ Million)
- 7.4.3 Intradermal Microinjection
  - 7.4.3.1 Overview
  - 7.4.3.2 Intradermal Microinjection: Intradermal Injection Market Revenue and Forecast to 2028 (US$ Million)
- 7.4.4 Microneedle Arrays
  - 7.4.4.1 Overview
  - 7.4.4.2 Microneedle Arrays: Intradermal Injection Market Revenue and Forecast to 2028 (US$ Million)
- 7.4.5 Tattoo Devices
  - 7.4.5.1 Overview
  - 7.4.5.2 Tattoo Devices: Intradermal Injection Market Revenue and Forecast to 2028 (US$ Million)
7.5 Without Needles
- 7.5.1 Overview
- 7.5.2 Without Needles: Intradermal Injection Market Revenue and Forecast to 2028 (US$ Million)
- 7.5.3 Intradermal Liquid Jet Injectors
  - 7.5.3.1 Overview
  - 7.5.3.2 Intradermal Liquid Jet Injectors: Intradermal Injection Market Revenue and Forecast to 2028 (US$ Million)
- 7.5.4 Ballistic Intradermal Injectors
  - 7.5.4.1 Overview
  - 7.5.4.2 Ballistic Intradermal Injectors: Intradermal Injection Market Revenue and Forecast to 2028 (US$ Million)

8. MEA Intradermal Injections Market Revenue and Forecasts To 2028 - Application

8.1 Overview
8.2 MEA Intradermal Injections Market Share by Application - 2021 & 2028 (%)
8.3 Tuberculin Skin Testing
- 8.3.1 Overview
- 8.3.2 Tuberculin Skin Testing Market Revenue and Forecast to 2028 (US$ Million)
8.4 Allergy Testing
- 8.4.1 Overview
- 8.4.2 Allergy Testing Market Revenue and Forecast to 2028 (US$ Million)
8.5 Local Aesthetics
- 8.5.1 Overview
- 8.5.2 Local Aesthetics Market Revenue and Forecast to 2028 (US$ Million)
8.6 OTHERS
- 8.6.1 Overview
- 8.6.2 Others Market Forecast and Analysis

9. MEA Intradermal Injections Market Analysis - End User

9.1 Overview
9.2 MEA Intradermal Injections Market, By End User, 2021 & 2028 (%)
9.3 Hospitals
- 9.3.1 Overview
- 9.3.2 Hospitals: Intradermal Injections Market Revenue and Forecast to 2028 (US$ Million)
9.4 Diagnostic Laboratories
- 9.4.1 Overview
- 9.4.2 Diagnostic Laboratories: Intradermal Injections Market Revenue and Forecast to 2028 (US$ Million)
9.5 Academic and Research Institutes
- 9.5.1 Overview
- 9.5.2 Academic and Research Institutes: Intradermal Injections Market Revenue and Forecast to 2028 (US$ Million)
9.6 OTHERS
- 9.6.1 Overview
- 9.6.2 Others: Intradermal Injections Market Revenue and Forecast to 2028 (US$ Million)

10. MEA Intradermal Injections Market Revenue and Forecasts To 2028 - Country Analysis

10.1 Middle East & Africa Intradermal Injections Market Revenue and Forecasts To 2028
- 10.1.1 Overview
- 10.1.3 Middle East & Africa Intradermal Injections Market Revenue and Forecasts to 2028, By Country (%)
  - 10.1.3.1 UAE: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
    - 10.1.3.1.1 Overview
    - 10.1.3.1.2 UAE: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
    - 10.1.3.1.3 UAE: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
    - 10.1.3.1.3.1 UAE: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
    - 10.1.3.1.3.2 UAE: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
    - 10.1.3.1.4 UAE: Intradermal Injections Market Revenue and Forecasts To 2028, By Application (US$ Million)
    - 10.1.3.1.5 UAE: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  - 10.1.3.2 Saudi Arabia: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
    - 10.1.3.2.1 Overview
    - 10.1.3.2.2 Saudi Arabia: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
    - 10.1.3.2.3 Saudi Arabia: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
    - 10.1.3.2.3.1 Saudi Arabia: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
    - 10.1.3.2.3.2 Saudi Arabia: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
    - 10.1.3.2.4 Saudi Arabia: Intradermal Injections Market Revenue and Forecasts To 2028, By Application (US$ Million)
    - 10.1.3.2.5 Saudi Arabia: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  - 10.1.3.3 South Africa: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
    - 10.1.3.3.1 Overview
    - 10.1.3.3.2 South Africa Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
    - 10.1.3.3.3 South Africa: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
    - 10.1.3.3.3.1 South Africa: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
    - 10.1.3.3.3.2 South Africa: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
    - 10.1.3.3.4 South Africa: Intradermal Injections Market Revenue and Forecasts To 2028, By Application (US$ Million)
    - 10.1.3.3.5 South Africa: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  - 10.1.3.4 Rest of Middle East and Africa: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
    - 10.1.3.4.1 Overview
    - 10.1.3.4.2 Rest of Middle East and Africa: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
    - 10.1.3.4.3 Rest of Middle East & Africa: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
    - 10.1.3.4.3.1 Rest of Middle East & Africa: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
    - 10.1.3.4.3.2 Rest of Middle East & Africa: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
    - 10.1.3.4.4 Rest of Middle East & Africa: Intradermal Injections Market Revenue and Forecasts To 2028, By Application (US$ Million)
    - 10.1.3.4.5 Rest of Middle East and Africa: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)

11. Industry Landscape

11.1 Overview
11.2 Developments
- 11.2.1 Overview

12. Company Profiles

12.1 BD
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 West Pharmaceutical Services, Inc.
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Terumo Corporation
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 NanoPass
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Pharmajet
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Idevax
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 EUNSUNG GLOBAL
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Crossject
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Cardinal Health Inc.
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Hindustan Syringes and Medical Devices Ltd
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms